Cryo-Cell International
CCEL · NYSE American
$4.75+$0.10 (+2.15%)TodayMarket closed ·
Prev close $4.65
Who owns CCEL
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 46.5% of CCEL’s shares.
- Portnoy (David I)13.6%
- Portnoy (Mark)11.6%
- Camac Partners, LLC6.8%
- Fleishman (Adam)6.3%
- Next 6 largest institutions8.1%
- All other shareholders53.5%
| Holder | Shares | % of shares |
|---|---|---|
| Portnoy (David I) | 1.10M | 13.63% |
| Portnoy (Mark) | 935.77K | 11.61% |
| Camac Partners, LLC | 551.08K | 6.84% |
| Fleishman (Adam) | 509.00K | 6.32% |
| SFI Advisors LLC | 165.30K | 2.05% |
| Vanguard Capital Management, LLC | 164.98K | 2.05% |
| The MassMutual Trust Company, FSB | 111.03K | 1.38% |
| Mikulinsky (Oleg) | 104.35K | 1.29% |
| Berger (Harold D) | 57.90K | 0.72% |
| Taymans (Jill M) | 52.90K | 0.66% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 94.69K | 1.17% |
| Vanguard Extended Market Index Fund | 45.31K | 0.56% |
| Fidelity Extended Market Index Fund | 23.11K | 0.29% |
| Fidelity Total Market Index Fund | 8.56K | 0.11% |
| Fidelity Series Total Market Index Fund | 6.90K | 0.09% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of CCEL in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| PORTNOY DAVID | Other | 600.19K | $799.99K |
| PORTNOY DAVID | Other | 600.19K | $799.99K |
| TAYMANS JILL M | Option exercise | 7.50K | $23.25K |
| TAYMANS JILL M | Option exercise | 7.50K | $23.25K |
Short interest
Settled Sep 30, 2026
- Shares short
- 6.42K
- Days to cover
- 1.00
- % of shares outstanding
- 0.08%
- Average daily volume
- 7.89K
- Change since last report
- −29.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.